Litcius/Paper detail

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Alexander M. Menzies, Rodabe N. Amaria, Elisa A. Rozeman, Alexander C. Huang, Michael T. Tetzlaff, Bart A. van de Wiel, Serigne Lo, Ahmad A. Tarhini, Elizabeth M. Burton, Thomas E. Pennington, Robyn P.M. Saw, Xiaowei Xu, Giorgos C. Karakousis, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Michael A. Davies, Tara C. Mitchell, Hussein A. Tawbi, Richard A. Scolyer, Jennifer A. Wargo, Christian U. Blank, Georgina V. Long

2021Nature Medicine431 citationsDOI

Topics & Concepts

IpilimumabMedicineImmunotherapySurrogate endpointNeoadjuvant therapyOncologyInternal medicineMelanomaPathologicalNivolumabClinical trialTargeted therapyClinical endpointCombination therapyBreslow ThicknessComplete responseCancerChemotherapyCancer researchSentinel lymph nodeBreast cancerCutaneous Melanoma Detection and ManagementCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways